{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T03:12:18Z","timestamp":1785726738061,"version":"3.56.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-D113092"],"award-info":[{"award-number":["TSGH-D113092"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-D113108, TSGH-D114105, and TSGH-D115115"],"award-info":[{"award-number":["TSGH-D113108, TSGH-D114105, and TSGH-D115115"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005937","name":"Cheng Hsin General Hospital Foundation","doi-asserted-by":"publisher","award":["CHNDMC-114-03 and CHNDMC-115-12"],"award-info":[{"award-number":["CHNDMC-114-03 and CHNDMC-115-12"]}],"id":[{"id":"10.13039\/501100005937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-40-05-GMM and AS-GC-110-MD02"],"award-info":[{"award-number":["AS-40-05-GMM and AS-GC-110-MD02"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04878-6","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T04:47:34Z","timestamp":1776228454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genome-wide association analysis of treatment response to onabotulinumtoxinA in Han Chinese patients with chronic migraine: a pilot study"],"prefix":"10.1186","volume":"26","author":[{"given":"Yu-Chin","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Sung","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Kuang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Lin","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Kai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-I","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Kuan","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hao","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Sheng","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Chi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"8","key":"4878_CR1","doi-asserted-by":"publisher","first-page":"333102424126730","DOI":"10.1177\/03331024241267309","volume":"44","author":"MFP Peres","year":"2024","unstructured":"Peres MFP, Sacco S, Pozo-Rosich P, Tassorelli C, Ahmed F, Burstein R, Ashina S, Uluduz D, Husoy AK, Steiner TJ. Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action. Cephalalgia. 2024;44(8):3331024241267309.","journal-title":"Cephalalgia"},{"key":"4878_CR2","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018, 38(1):1-211.","DOI":"10.1177\/0333102417738202"},{"issue":"1","key":"4878_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s10194-016-0699-5","volume":"17","author":"TJ Steiner","year":"2016","unstructured":"Steiner TJ, Stovner LJ, Vos T. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain. 2016;17(1):104.","journal-title":"J Headache Pain"},{"issue":"5","key":"4878_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1468-2982.2009.01941.x","volume":"30","author":"JL Natoli","year":"2010","unstructured":"Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L, Lipton RB. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2010;30(5):599\u2013609.","journal-title":"Cephalalgia"},{"issue":"4","key":"4878_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1177\/0333102412468677","volume":"33","author":"RJ Stark","year":"2013","unstructured":"Stark RJ, Ravishankar K, Siow HC, Lee KS, Pepperle R, Wang SJ. Chronic migraine and chronic daily headache in the Asia-Pacific region: a systematic review. Cephalalgia. 2013;33(4):266\u201383.","journal-title":"Cephalalgia"},{"issue":"4","key":"4878_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11916-024-01228-4","volume":"28","author":"PK Yeh","year":"2024","unstructured":"Yeh PK, An YC, Hung KS, Yang FC. Influences of Genetic and Environmental Factors on Chronic Migraine: A Narrative Review. Curr Pain Headache Rep. 2024;28(4):169\u201380.","journal-title":"Curr Pain Headache Rep"},{"issue":"6","key":"4878_CR7","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","volume":"50","author":"DW Dodick","year":"2010","unstructured":"Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF, Group PCMS. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010;50(6):921\u201336.","journal-title":"Headache"},{"issue":"4","key":"4878_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00702-007-0728-2","volume":"115","author":"FJ Erbguth","year":"2008","unstructured":"Erbguth FJ. From poison to remedy: the chequered history of botulinum toxin. J Neural Transm (Vienna). 2008;115(4):559\u201365.","journal-title":"J Neural Transm (Vienna)"},{"key":"4878_CR9","doi-asserted-by":"crossref","unstructured":"Shaterian N, Shaterian N, Ghanaatpisheh A, Abbasi F, Daniali S, Jahromi MJ, Sanie MS, Abdoli A. Botox (OnabotulinumtoxinA) for Treatment of Migraine Symptoms: A Systematic Review. Pain Res Manag 2022, 2022:3284446.","DOI":"10.1155\/2022\/3284446"},{"issue":"2","key":"4878_CR10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s40122-020-00199-9","volume":"9","author":"SD Silberstein","year":"2020","unstructured":"Silberstein SD, Diener HC, Dodick DW, Manack Adams A, DeGryse RE, Lipton RB. The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine. Pain Ther. 2020;9(2):695\u2013707.","journal-title":"Pain Ther"},{"issue":"1","key":"4878_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s10194-019-1030-z","volume":"20","author":"C Stark","year":"2019","unstructured":"Stark C, Stark R, Limberg N, Rodrigues J, Cordato D, Schwartz R, Jukic R. Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study. J Headache Pain. 2019;20(1):81.","journal-title":"J Headache Pain"},{"issue":"1","key":"4878_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/PRS.0000000000005111","volume":"143","author":"E Bruloy","year":"2019","unstructured":"Bruloy E, Sinna R, Grolleau JL, Bout-Roumazeilles A, Berard E, Chaput B. Botulinum Toxin versus Placebo: A Meta-Analysis of Prophylactic Treatment for Migraine. Plast Reconstr Surg. 2019;143(1):239\u201350.","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"4878_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s10194-018-0918-3","volume":"19","author":"M Vikelis","year":"2018","unstructured":"Vikelis M, Argyriou AA, Dermitzakis EV, Spingos KC, Makris N, Kararizou E. Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment. J Headache Pain. 2018;19(1):87.","journal-title":"J Headache Pain"},{"issue":"2","key":"4878_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41588-021-00990-0","volume":"54","author":"H Hautakangas","year":"2022","unstructured":"Hautakangas H, Winsvold BS, Ruotsalainen SE, Bjornsdottir G, Harder AVE, Kogelman LJA, Thomas LF, Noordam R, Benner C, Gormley P, et al. Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles. Nat Genet. 2022;54(2):152\u201360.","journal-title":"Nat Genet"},{"issue":"9","key":"4878_CR15","doi-asserted-by":"publisher","first-page":"e16372","DOI":"10.1111\/ene.16372","volume":"31","author":"YF Wang","year":"2024","unstructured":"Wang YF, Yang FC, Chen LA, Chang TY, Su HC, Yang CP, Tu YH, Tzeng YS, Chen SP, Fuh JL, et al. Comparative effectiveness and tolerability of calcitonin gene-related peptide (CGRP) monoclonal antibodies and onabotulinumtoxinA in chronic migraine: A multicenter, real-world study in Taiwan. Eur J Neurol. 2024;31(9):e16372.","journal-title":"Eur J Neurol"},{"issue":"1","key":"4878_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s10194-024-01850-y","volume":"25","author":"YC An","year":"2024","unstructured":"An YC, Hung KS, Liang CS, Tsai CK, Tsai CL, Chen SJ, Lin YK, Lin GY, Yeh PK, Yang FC. Genetic variants associated with response to anti-CGRP monoclonal antibody therapy in a chronic migraine Han Chinese population. J Headache Pain. 2024;25(1):149.","journal-title":"J Headache Pain"},{"issue":"1","key":"4878_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s10194-019-0989-9","volume":"20","author":"R Moreno-Mayordomo","year":"2019","unstructured":"Moreno-Mayordomo R, Ruiz M, Pascual J, Gallego de la Sacristana M, Vidriales I, Sobrado M, Cernuda-Morollon E, Gago-Veiga AB, Garcia-Azorin D, Telleria JJ, et al. CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with OnabotulinumtoxinA. J Headache Pain. 2019;20(1):39.","journal-title":"J Headache Pain"},{"issue":"1","key":"4878_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/head.13211","volume":"58","author":"C Dominguez","year":"2018","unstructured":"Dominguez C, Vieites-Prado A, Perez-Mato M, Sobrino T, Rodriguez-Osorio X, Lopez A, Campos F, Martinez F, Castillo J, Leira R. CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study. Headache. 2018;58(1):78\u201387.","journal-title":"Headache"},{"issue":"6 Suppl 1","key":"4878_CR19","first-page":"S20","volume":"56","author":"WF Stewart","year":"2001","unstructured":"Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20\u201328.","journal-title":"Neurology"},{"issue":"1","key":"4878_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41525-021-00178-9","volume":"6","author":"CY Wei","year":"2021","unstructured":"Wei CY, Yang JH, Yeh EC, Tsai MF, Kao HJ, Lo CZ, Chang LP, Lin WJ, Hsieh FJ, Belsare S, et al. Genetic profiles of 103,106 individuals in the Taiwan Biobank provide insights into the health and history of Han Chinese. NPJ Genom Med. 2021;6(1):10.","journal-title":"NPJ Genom Med"},{"issue":"3","key":"4878_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559\u201375.","journal-title":"Am J Hum Genet"},{"issue":"10","key":"4878_CR22","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/nprot.2015.105","volume":"10","author":"H Yang","year":"2015","unstructured":"Yang H, Wang K. Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR. Nat Protoc. 2015;10(10):1556\u201366.","journal-title":"Nat Protoc"},{"issue":"7571","key":"4878_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"C Genomes Project","year":"2015","unstructured":"Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68\u201374.","journal-title":"Nature"},{"issue":"11","key":"4878_CR24","doi-asserted-by":"publisher","first-page":"100197","DOI":"10.1016\/j.xgen.2022.100197","volume":"2","author":"YA Feng","year":"2022","unstructured":"Feng YA, Chen CY, Chen TT, Kuo PH, Hsu YH, Yang HI, Chen WJ, Su MW, Chu HW, Shen CY, et al. Taiwan Biobank: A rich biomedical research database of the Taiwanese population. Cell Genom. 2022;2(11):100197.","journal-title":"Cell Genom"},{"issue":"6509","key":"4878_CR25","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"GT Consortium","year":"2020","unstructured":"Consortium GT. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369(6509):1318\u201330.","journal-title":"Science"},{"issue":"1","key":"4878_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44\u201357.","journal-title":"Nat Protoc"},{"issue":"1","key":"4878_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13059-023-03126-1","volume":"25","author":"CE Breeze","year":"2024","unstructured":"Breeze CE, Haugen E, Gutierrez-Arcelus M, Yao X, Teschendorff A, Beck S, Dunham I, Stamatoyannopoulos J, Franceschini N, Machiela MJ, et al. FORGEdb: a tool for identifying candidate functional variants and uncovering target genes and mechanisms for complex diseases. Genome Biol. 2024;25(1):3.","journal-title":"Genome Biol"},{"issue":"4","key":"4878_CR28","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.gpb.2020.10.007","volume":"19","author":"L Yin","year":"2021","unstructured":"Yin L, Zhang H, Tang Z, Xu J, Yin D, Zhang Z, Yuan X, Zhu M, Zhao S, Li X, et al. rMVP: A Memory-efficient, Visualization-enhanced, and Parallel-accelerated Tool for Genome-wide Association Study. Genomics Proteom Bioinf. 2021;19(4):619\u201328.","journal-title":"Genomics Proteom Bioinf"},{"key":"4878_CR29","doi-asserted-by":"publisher","first-page":"177206","DOI":"10.1016\/j.ejphar.2024.177206","volume":"987","author":"X Ke","year":"2025","unstructured":"Ke X, Cai H, Chen Y, Chen G. Exploring the therapeutic potential of TRPC channels in chronic pain: An investigation into their mechanisms, functions, and prospects. Eur J Pharmacol. 2025;987:177206.","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 1","key":"4878_CR30","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.pain.2013.07.021","volume":"154","author":"R Noseda","year":"2013","unstructured":"Noseda R, Burstein R. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain. 2013;154(Suppl 1):S44\u201353.","journal-title":"Pain"},{"key":"4878_CR31","doi-asserted-by":"publisher","first-page":"765181","DOI":"10.3389\/fnmol.2021.765181","volume":"14","author":"CF Cohen","year":"2021","unstructured":"Cohen CF, Prudente AS, Berta T, Lee SH. Transient Receptor Potential Channel 4 Small-Molecule Inhibition Alleviates Migraine-Like Behavior in Mice. Front Mol Neurosci. 2021;14:765181.","journal-title":"Front Mol Neurosci"},{"key":"4878_CR32","doi-asserted-by":"publisher","first-page":"174480691983657","DOI":"10.1177\/1744806919836570","volume":"15","author":"L Zhang","year":"2019","unstructured":"Zhang L, Kunkler PE, Knopp KL, Oxford GS, Hurley JH. Role of intraganglionic transmission in the trigeminovascular pathway. Mol Pain. 2019;15:1744806919836570.","journal-title":"Mol Pain"},{"issue":"10","key":"4878_CR33","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/j.1460-2075.1994.tb06523.x","volume":"13","author":"S Humbert","year":"1994","unstructured":"Humbert S, van Vuuren H, Lutz Y, Hoeijmakers JH, Egly JM, Moncollin V. p44 and p34 subunits of the BTF2\/TFIIH transcription factor have homologies with SSL1, a yeast protein involved in DNA repair. EMBO J. 1994;13(10):2393\u20138.","journal-title":"EMBO J"},{"issue":"22","key":"4878_CR34","doi-asserted-by":"publisher","first-page":"13043","DOI":"10.1093\/nar\/gkx970","volume":"45","author":"M Okuda","year":"2017","unstructured":"Okuda M, Nakazawa Y, Guo C, Ogi T, Nishimura Y. Common TFIIH recruitment mechanism in global genome and transcription-coupled repair subpathways. Nucleic Acids Res. 2017;45(22):13043\u201355.","journal-title":"Nucleic Acids Res"},{"key":"4878_CR35","doi-asserted-by":"publisher","first-page":"1127167","DOI":"10.3389\/fgene.2023.1127167","volume":"14","author":"L Hu","year":"2023","unstructured":"Hu L, Yin W, Ma Y, Zhang Q, Xu Q. Gene expression signature of human neuropathic pain identified through transcriptome analysis. Front Genet. 2023;14:1127167.","journal-title":"Front Genet"},{"key":"4878_CR36","unstructured":"NCBI Gene. SPOCK3 [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); [updated 2025; cited 2025 Mar 27]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/gene\/50859"},{"key":"4878_CR37","doi-asserted-by":"crossref","unstructured":"Xiao M, Xue J, Jin E. SPOCK: Master regulator of malignant tumors (Review). Mol Med Rep 2024, 30(6).","DOI":"10.3892\/mmr.2024.13355"},{"issue":"1","key":"4878_CR38","doi-asserted-by":"publisher","first-page":"13192","DOI":"10.1038\/s41598-021-92335-4","volume":"11","author":"TJ Eviston","year":"2021","unstructured":"Eviston TJ, Minaei E, Mueller SA, Ahmadi N, Ashford B, Clark JR, West N, Zhang P, Gupta R, Ranson M. Gene expression profiling of perineural invasion in head and neck cutaneous squamous cell carcinoma. Sci Rep. 2021;11(1):13192.","journal-title":"Sci Rep"},{"issue":"5","key":"4878_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.31083\/j.jin2105141","volume":"21","author":"L Raciti","year":"2022","unstructured":"Raciti L, Raciti G, Militi D, Casella C, Calabro RS. Chronic Migraine: A Narrative Review on the Use of Botulinum Toxin with Clinical Indications and Future Directions. J Integr Neurosci. 2022;21(5):141.","journal-title":"J Integr Neurosci"},{"key":"4878_CR40","doi-asserted-by":"crossref","unstructured":"Matak I, Bolcskei K, Bach-Rojecky L, Helyes Z. Mechanisms of Botulinum Toxin Type A Action on Pain. Toxins (Basel) 2019, 11(8).","DOI":"10.3390\/toxins11080459"},{"issue":"2","key":"4878_CR41","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1021\/bi0356698","volume":"43","author":"JE Keller","year":"2004","unstructured":"Keller JE, Cai F, Neale EA. Uptake of botulinum neurotoxin into cultured neurons. Biochemistry. 2004;43(2):526\u201332.","journal-title":"Biochemistry"},{"issue":"7","key":"4878_CR42","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/head.13849","volume":"60","author":"R Burstein","year":"2020","unstructured":"Burstein R, Blumenfeld AM, Silberstein SD, Manack Adams A, Brin MF. Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review. Headache. 2020;60(7):1259\u201372.","journal-title":"Headache"},{"issue":"1","key":"4878_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s10194-017-0811-5","volume":"18","author":"S Benemei","year":"2017","unstructured":"Benemei S, Cortese F, Labastida-Ramirez A, Marchese F, Pellesi L, Romoli M, Vollesen AL, Lampl C, Ashina M. School of Advanced Studies of the European Headache F: Triptans and CGRP blockade - impact on the cranial vasculature. J Headache Pain. 2017;18(1):103.","journal-title":"J Headache Pain"},{"issue":"2","key":"4878_CR44","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.nurt.2010.02.004","volume":"7","author":"L Edvinsson","year":"2010","unstructured":"Edvinsson L, Ho TW. CGRP receptor antagonism and migraine. Neurotherapeutics. 2010;7(2):164\u201375.","journal-title":"Neurotherapeutics"},{"issue":"4","key":"4878_CR45","doi-asserted-by":"publisher","first-page":"e42350","DOI":"10.1016\/j.heliyon.2025.e42350","volume":"11","author":"H Rahmatipour","year":"2025","unstructured":"Rahmatipour H, Shabestari SM, Benisi SZ, Samadikhah H. Pioneering pain management with botulinum toxin type A: From anti-inflammation to regenerative therapies. Heliyon. 2025;11(4):e42350.","journal-title":"Heliyon"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04878-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04878-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04878-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:02:37Z","timestamp":1779357757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04878-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4878"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04878-6","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by TSGH Institutional Review Board (protocol code TSGHIRB: 2-108-05-038).Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"347"}}